This appendix has been provided by the authors to give readers additional information about their work.

Download the PDF of Supplementary Appendix. The CAMMS223 Trial Investigators. Alemtuzumab vs. Interferon Beta-1a in Early Multiple Sclerosis. N Engl J Med 2008;359:1786-801.

This file is in Adobe Acrobat (PDF) format. If you have not installed and configured Acrobat Reader on your system, click here for instructions.